Sunday, July 27, 2025 4:11:26 PM
Ex, I'd agree with all you're saying with the exception of the possibility of NWBO being told under Orbis to apply to the UK, because they have the small but acceptable commercial production facility.
If that were done under Orbis, the application would really be one that would be evaluated by all the regulators involved with the agreement.
I'm not suggesting that this is the case, only that it's a possibility. I'm not aware of any approval coming through Orbis yet, perhaps there have been, but if not, could this be the first.
I don't believe they ever intend to say this is an Orbis filing because if the regulators don't agree, they don't want to say it failed. By never saying something is an Orbis filing they would never have to say the different regulators could not agree.
Approved products in one country generally will spread worldwide if the benefits are truly being seen. If benefits aren't seen, it's doubtful the product will be a financial success, and doubtful its approval will spread very far.
I believe that under Orbis a company will do what they're told to do and if that is to file with the UK, that's what they'd do.
Gary
If that were done under Orbis, the application would really be one that would be evaluated by all the regulators involved with the agreement.
I'm not suggesting that this is the case, only that it's a possibility. I'm not aware of any approval coming through Orbis yet, perhaps there have been, but if not, could this be the first.
I don't believe they ever intend to say this is an Orbis filing because if the regulators don't agree, they don't want to say it failed. By never saying something is an Orbis filing they would never have to say the different regulators could not agree.
Approved products in one country generally will spread worldwide if the benefits are truly being seen. If benefits aren't seen, it's doubtful the product will be a financial success, and doubtful its approval will spread very far.
I believe that under Orbis a company will do what they're told to do and if that is to file with the UK, that's what they'd do.
Gary
Bullish
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
